# COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

> **NCT05121662** · — · COMPLETED · sponsor: **Columbia University** · enrollment: 154 (actual)

## Conditions studied

- Multiple Sclerosis
- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05121662
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-29
- **Primary completion:** 2025-02-13
- **Final completion:** 2025-02-13
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2025-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05121662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05121662, "COVID-19 Vaccine Biomarker Study in Multiple Sclerosis". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05121662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*